The University of Chicago Header Logo

Connection

Michael Becker to Receptors, Tumor Necrosis Factor, Type I

Back to Details
This is a "connection" page, showing publications Michael Becker has written about Receptors, Tumor Necrosis Factor, Type I.
Michael Becker
Connection Strength
0.016
Receptors, Tumor Necrosis Factor, Type I
  1. Pilot trial on the use of etanercept and methylprednisolone as primary treatment for acute graft-versus-host disease. Biol Blood Marrow Transplant. 2005 Sep; 11(9):680-7.
    View in: PubMed
    Score: 0.016
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.